Cargando…

Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors

Gestational trophoblastic neoplasia (GTN) represents a group of diseases characterized by production of human chorionic gonadotropin (hCG). Since non-gestational tumors may occasionally secrete hCG, histopathological diagnosis is important for appropriate clinical management. However, a histopatholo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Openshaw, Mark R., Harvey, Richard A., Sebire, Neil J., Kaur, Baljeet, Sarwar, Naveed, Seckl, Michael J., Fisher, Rosemary A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776063/ https://www.ncbi.nlm.nih.gov/pubmed/26981554 http://dx.doi.org/10.1016/j.ebiom.2015.12.022

Ejemplares similares

Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours
por: Maher, Geoffrey J., et al.
Publicado: (2022)

Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours
por: Froeling, Fieke E. M., et al.
Publicado: (2019)

Abnormal villous morphology mimicking a hydatidiform mole associated with paternal trisomy of chromosomes 3,7,8 and unipaternal disomy of chromosome 11
por: Sebire, Neil J, et al.
Publicado: (2016)

Epithelioid trophoblastic tumor with antecedent molar pregnancy in an HIV‐positive patient
por: Black, Louisa, et al.
Publicado: (2023)

PREDICT‐GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?
por: Parker, Victoria L., et al.
Publicado: (2022)

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia
por: Agarwal, R, et al.
Publicado: (2012)

Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)
por: Chan Wah Hak, Charleen, et al.
Publicado: (2019)

Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide
por: Braga, Antonio, et al.
Publicado: (2019)

Diagnosis and management of gestational trophoblastic disease: 2021 update
por: Ngan, Hextan Y. S., et al.
Publicado: (2021)

Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009
por: Sita-Lumsden, A, et al.
Publicado: (2012)

The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours
por: Powles, T, et al.
Publicado: (2006)

The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours
por: Powles, T, et al.
Publicado: (2006)

Circulating Tumor DNA: A Potential Novel Diagnostic Approach in Gestational Trophoblastic Neoplasia
por: Bolze, Pierre-Adrien, et al.
Publicado: (2016)

Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy
por: Cortés-Charry, R., et al.
Publicado: (2021)

The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours
por: Blagden, S P, et al.
Publicado: (2002)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate
por: Porter, A., et al.
Publicado: (2021)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors
por: Yan, Weixin, et al.
Publicado: (2016)

Validation Studies for Single Circulating Trophoblast Genetic Testing as a Form of Noninvasive Prenatal Diagnosis
por: Vossaert, Liesbeth, et al.
Publicado: (2019)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?
por: Powles, T, et al.
Publicado: (2006)

A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
por: Powles, T, et al.
Publicado: (2007)

Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis
por: Zhou, Xiao, et al.
Publicado: (2022)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(−1)
por: McGrath, S, et al.
Publicado: (2010)

Primary hepatic metastatic epitheloid trophoblastic tumor of the uterus treated with multimodal therapy including pembrolizumab and thermoablation. Case report of an extremely rare disease and review of the literature
por: Helbig, M., et al.
Publicado: (2023)

External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease
por: Kerkmeijer, L G, et al.
Publicado: (2009)

The potential of serum fetal DNA for early diagnosis of gestational trophoblastic disease
por: Bademkıran, Muhammed Hanifi, et al.
Publicado: (2019)

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
por: Zhu, Guanhua, et al.
Publicado: (2021)

Gestational trophoblastic neoplasia of intermediate trophoblasts: Epithelioid trophoblastic tumor and placental site trophoblastic tumor, a study of morphologic, immunohistochemical, and next generation sequencing
por: Öz Atalay, Fatma, et al.
Publicado: (2023)

Trophoblast and Its Tumors
por: Galton, Michael
Publicado: (1961)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Clinical correlates of circulating cell-free DNA tumor fraction
por: Bredno, Joerg, et al.
Publicado: (2021)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
por: Manier, S., et al.
Publicado: (2018)

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements
por: You, B, et al.
Publicado: (2013)

Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
por: Salvianti, Francesca, et al.
Publicado: (2016)

The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA
por: Henriksen, Tenna V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5g2smn7e6npmoe9j4tvs5banb